Nimish P Shah insider trades
Open-market stock purchases and sales by Nimish P Shah, Director at Apogee Therapeutics, Inc, from SEC Form 4 filings since Mar 18, 2021.
Track record: 17% of 6 scored buys are up 5% or more since purchase, averaging -31%.